Tuberculosis in patientes treated with tumor necrosis factor-alpha antagonists living in an endemic area. Is the risk worthwhile?

Adriana Rojas-Villarraga, Carlos Andrés Agudelo, Ricardo Pineda-Tamayo, Alvaro Porras, Gustavo Matute, Juan Manuel Anaya

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Tuberculosis in patientes treated with tumor necrosis factor-alpha antagonists living in an endemic area. Is the risk worthwhile?'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds